Impact of Diabetic Peripheral Neuropathy on Health-Related Quality of Life in Type 2 Diabetes: A Cross-Sectional EQ-5D-3L Study
Ankara Üniversitesi Tıp Fakültesi Mecmuası · 30.06.2026 · 79 (2) · 205-215
DOI: 10.65092/autfm.1860563 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Ankara Üniversitesi Tıp Fakültesi Mecmuası, online erschienen am 30.06.2026. Verfasst von Sinem Başak Tan Öksüz und 9 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
Diabetic peripheral neuropathy (DPN), a frequent microvascular complication of type 2 diabetes mellitus (T2DM), substantially compromises patients’ health-related quality of life (HRQoL). In this study, the impact of DPN on HRQoL was evaluated with the EuroQol-5D-3L (EQ-5D-3L) and Visual Analog Scale (VAS) together with an evaluation of the clinical and demographic determinants related to HRQoL.
Methods
Our study was conducted on 308 patients diagnosed with T2DM at a tertiary endocrinology clinic. DPN was evaluated through neurological examination, deep tendon reflexes, monofilament testing, and vibration perception threshold (VPT) measurements. HRQoL was evaluated with the culturally validated Turkish version of EQ-5D-3L and VAS.
Results
DPN was diagnosed in 114 patients (37.0%). Mean EQ-5D-3L index and VAS scores were lower in patients with DPN than those without (0.44 ± 0.30 vs 0.73 ± 0.20; 60.5 ± 21.6 vs 68.5 ± 19.7; p < 0.001). Pain/discomfort and anxiety/depression contributed most to reduced HRQoL. VPT values were found to be significantly and inversely correlated with EQ-5D-3L and VAS results. Subgroup analyses indicated that lower educational attainment and combined insulin–oral treatment were related to poorer HRQoL, while the presence of additional microvascular complications did not further reduce scores.
Conclusion
DPN significantly compromises HRQoL in T2DM, with pain and anxiety as dominant drivers. Objective neuropathy severity correlated with poorer perceived health, underscoring the need for early detection and comprehensive management. While the cross-sectional nature of this study exludes causal inference, the findings highlight the importance of integrating neuropathy-specific interventions into patient-centered diabetes care.
Zitieren
APA
Öksüz, S. B. T., Demirtel, A. A., Apaydın, B., Tumluer, E. B., Günay, M., Bayrak, M. Ç., Saygı, S., Yorulmaz, Z. Z., Emral, R., & Canpolat, A. G. (2026). Impact of Diabetic Peripheral Neuropathy on Health-Related Quality of Life in Type 2 Diabetes: A Cross-Sectional EQ-5D-3L Study. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 79(2), 205-215. https://doi.org/10.65092/autfm.1860563
Vancouver
Öksüz SBT, Demirtel AA, Apaydın B, Tumluer EB, Günay M, Bayrak MÇ, et al. Impact of Diabetic Peripheral Neuropathy on Health-Related Quality of Life in Type 2 Diabetes: A Cross-Sectional EQ-5D-3L Study. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2026;79(2):205-215. doi:10.65092/autfm.1860563
BibTeX
@article{ksz2026,
author = {Öksüz, Sinem Başak Tan and Demirtel, Ahmet Alp and Apaydın, Beyzanur and Tumluer, Emir Batu and Günay, Melisa and Bayrak, Muhammed Çağrı and Saygı, Sena and Yorulmaz, Zeynep Zülal and Emral, Rifat and Canpolat, Asena Gökçay},
title = {Impact of Diabetic Peripheral Neuropathy on Health-Related Quality of Life in Type 2 Diabetes: A Cross-Sectional EQ-5D-3L Study},
journal = {Ankara Üniversitesi Tıp Fakültesi Mecmuası},
year = {2026},
volume = {79},
number = {2},
pages = {205--215},
doi = {10.65092/autfm.1860563}
}
EUVIMED